title: Comment on: Hölscher AH, Bollschweiler E, Bogoevski D, Schmidt H, Semrau R, Izbicki JR. Prognostic impact of neoadjuvant chemoradiation in cT3 oesophageal cancer – A propensity score matched analysis. Eur J Cancer. 2014;50(17):2950-7.
authors.affiliation: Department of Surgery, University Medical Center Utrecht, The Netherlands; Department of Radiotherapy, University Medical Center Utrecht, The Netherlands. Electronic address: P.S.N.vanRossum-2@umcutrecht.nl.
authors.forename: Peter S N
authors.initials: PS
authors.lastname: van Rossum
authors.affiliation: Department of Surgery, University Medical Center Utrecht, The Netherlands; Department of Radiotherapy, University Medical Center Utrecht, The Netherlands.
authors.forename: Lucas
authors.initials: L
authors.lastname: Goense
authors.affiliation: Department of Surgery, University Medical Center Utrecht, The Netherlands.
authors.forename: Richard
authors.initials: R
authors.lastname: van Hillegersberg
authors.affiliation: Department of Surgery, University Medical Center Utrecht, The Netherlands. Electronic address: J.P.Ruurda@umcutrecht.nl.
authors.forename: Jelle P
authors.initials: JP
authors.lastname: Ruurda
mesh_terms: D000230:Adenocarcinoma / Q000628:therapy*; D002294:Carcinoma, Squamous Cell / Q000628:therapy*; D059248:Chemoradiotherapy / Q000379:methods*; D004938:Esophageal Neoplasms / Q000628:therapy*; D005260:Female; D006801:Humans; D008297:Male